Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 18, 2021 | PathAI | $165.0M Series C | Daniel Saul Sundheim, Kaiser Permanente | 8VC, Adage, Biospring Partners, Bristol Myers Squibb, General Atlantic, General Catalyst, KdT Ventures, Labcorp, Polaris Partners, Refactor Capital, Tiger Global |